More corporate boards are tightening executive security and travel rules, disclosures show, as companies cite heightened threat concerns and point to a string of high-profile attacks and alleged kidnappings that security advisers say are changing how CEOs and directors…
Eli Lilly in Advanced Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Aprile 19, 2026
Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, The Wall Street Journal reported on Sunday.[#item_full_content]
